Moolec Science (MLECW) Payables (2022 - 2026)
Moolec Science (MLECW) posted Payables of $57.8 million for Q1 2026, up 20.25% sequentially from $48.1 million in Q4 2025.
Moolec Science (MLECW) Payables (2022 - 2026) Analysis & Trends
Moolec Science has reported Payables for 5 years, with the latest figure at $57.8 million in Q1 2026.
- Quarterly Payables changed N/A year-over-year to $57.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $57.8 million (changed N/A YoY) and the FY2025 annual result came in at $234.5 million, down 41.88% from the prior year.
- Payables climbed to $57.8 million in Q1 2026 per MLECW's latest filing, from $48.1 million in the prior quarter.
- Over five years, Payables peaked at $403.4 million in Q2 2024 and troughed at $1.2 million in Q2 2022.
- A 5-year average of $74.2 million and a median of $7.8 million in 2023 frame the typical range for Payables.
- The sharpest annual moves came in 2023 and 2024: Payables soared 15189.37% in 2023, then plunged 65.47% in 2024.
- Over 5 years, Payables stood at $8.8 million in 2022, then slumped by 49.22% to $4.5 million in 2023, then fell by 29.67% to $3.1 million in 2024, then surged by 1433.87% to $48.1 million in 2025, then climbed by 20.25% to $57.8 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $57.8 million, $48.1 million, and $234.5 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | 57.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.80 Mn |
| Dec 31, 2025 | 48.07 Mn |
| Jun 30, 2025 | 234.48 Mn |
| Dec 31, 2024 | 3.13 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Jun 30, 2024 | 403.45 Mn |
| Mar 31, 2024 | 3.28 Mn |
| Dec 31, 2023 | 4.46 Mn |
| Sep 30, 2023 | 7.76 Mn |
| Jun 30, 2023 | 187.48 Mn |
| Mar 31, 2023 | 1.38 Mn |
| Dec 31, 2022 | 8.77 Mn |
| Jun 30, 2022 | 1.23 Mn |